Surna Inc. (OTCQB: SRNA) announced today operating and financial results for the three and nine months ended September 30, 2019.
We will be hosting an investor conference call to discuss our Q3 2019 financial results and to provide updates on our recent business developments and our strategic growth plan. The call will be held on Wednesday, November 20, 2019 at 4:00 p.m. Eastern Time.
To access the investor call via telephone:
Dial-In Number: 1-973-528-0008
Access Code: 485475
To access the investor call via the Internet:
Webcast URL: https://www.webcaster4.com/Webcast/Page/2020/31743
Interested parties, with contact information supplied, may submit questions to the Company prior to the call to email@example.com. These questions, along with all live questions, will be answered in the time available.
For those unable to participate in the investor conference call at that time, a replay will be available on the investor relations section of our website at https://surna.com/investor-relations/ beginning on November 21, 2019 at 4:00 p.m. Eastern Time (and will remain available until February 1, 2020).
Surna had another record-setting quarter in Q3 2019:
|●||Our Q3 2019 revenue was $5.5 million—a record. Our Q3 2019 revenue represents an increase of 66% compared to Q3 2018 and 31% compared to Q2 2019 revenue of $4.2 million—which was our then previous record high. Third quarter revenue reflects $3.9 million recognized from two expansion project contracts we signed with a single multi-facility operator in Q2 2019.|
|●||Our third quarter gross margin was 28.6%, a decrease from 34.4% in Q2 2019, as we took advantage of larger project opportunities that included a high proportion of non-proprietary products. Our gross margin for the first nine months of 2019 was 30.6%, an increase of 3.5 percentage points over the gross margin of 27.1% for the first nine months of 2018.|
|●||For the first time, we achieved back-to-back quarters of both positive operating and net income. For Q3 2019, operating income was $277,000 and net income was $222,000, each a quarterly record for us. Moreover, our adjusted operating income was $421,000, a key management metric and point of focus.|
|●||As of September 30, 2019, our cash was $2,000,000. We generated $1,750,000 in cash flow from our operating activities in the first nine months of 2019. We also reduced our working capital deficit to $771,000 as of September 30, 2019, a decrease over the last six months of $857,000, from $1,628,000 as of March 31, 2019.|
Tony McDonald, the Company’s CEO, stated: “We are extremely pleased with our second straight quarter of record revenue and profits. We continue to focus on our two key financial metrics: revenue growth and profitability. We also improved our cash position significantly—with a quarter-end cash balance of $2.0 million—and strong operating cash flows year-to-date. We believe the numbers speak for themselves.”
ther highlights during Q3 2019 include:
|●||During Q3 2019, we entered into contracts for our SentryIQTM sensors, controls and automation platform with two multi-facility operators which totaled $218,000 as well as two controls contracts with larger independent cultivators for $295,000. We believe our expanding controls business positions us for a more significant role in the technology and automation advancement of indoor grow facilities. Through September 30, 2019, we signed seven controls contracts for a total aggregate contract value of $687,000.|
|●||In June 2019, we delivered our first custom-designed ducted air handling system, which is now offered as an alternative to our new and improved ductless fan coil units. Our ability to offer larger capacity air handling systems should provide greater opportunities for us to work with multi-facility operators. Through September 30, 2019, we entered into sales contracts of $2,860,000 for our ducted air handling systems, of which we recognized revenue of $2,270,000.|
Bookings and Backlog
During Q3 2019, we executed new sales contracts with a total contract value of $2,441,000. During this same period, we cancelled two outstanding sales contracts with a total remaining contract value of $47,000 and had positive change orders of $250,000. After adjustments for these cancellations and change orders, our net bookings in Q3 2019 were $2,644,000, representing a decrease of $3,046,000 (or 54%) from net bookings of $5,690,000 in Q2 2019.
During Q3 2019, we believe certain Canadian prospects delayed new or expansion projects as access to capital has recently tightened due to current market conditions in that country. However, we continue to pursue several initiatives to drive our bookings and revenue growth. Among other activities, we sharpened and expanded our marketing outreach in an effort to increase the quantity of qualified sales leads. During the third quarter, we also added three sales representatives. Finally, we believe our introduction of several new products to the market, including custom air-handlers, 4-pipe fan coil units, and our SentryIQTM controls system, will also contribute to our future growth.
To date, we have identified several business verticals, or silos, that we believe could be logical and natural complements to our climate control business, including: lighting, fertigation (automated process of delivering nutrients and water to plants), benches (customized systems to optimize use of the growing space), cultivation management technology (software), consumables (growing, packaging, facility and lab supplies), and operational improvement analytics (modeling, data aggregation and artificial intelligence). Initially, we will seek to form strategic alliances, such as distribution, reseller, co-marketing or product development agreements, with select companies which are consistent with our strategic direction. Through at least the first half of 2020, our strategic focus will be to establish these types of strategic alliances.
Link to Strategic Plan can be found at the end of the press release.
Over time, it is possible that some of these strategic alliances may evolve into acquisition targets. Under the right circumstances and at the appropriate time, we believe acquisitions and related capital infusions of growth equity, combined with the proper execution of our growth plan, can accelerate our progress towards consistent cash operating profitability. Our goal for 2021 is to obtain a Nasdaq listing and implement an aftermarket support program that will result in a widely held, actively traded, and fully valued public company.
About Surna Inc.
Surna Inc. (www.surna.com) is a Boulder, Colorado-based company that designs, engineers and manufactures environmental control and air sanitation systems for commercial, state- and provincial-regulated indoor cannabis cultivation facilities in the U.S. and Canada. Our engineering and technical team provides energy and water efficient solutions that allow growers to meet the unique demands of a cannabis cultivation environment through precise temperature, humidity, and process controls and to satisfy the evolving code and regulatory requirements being imposed at the state, provincial and local levels. We have been involved in consulting, equipment sales and/or full-scale design for over 800 grow facilities since 2006 making us a trusted resource for indoor environmental design and control management for the cannabis industry.
Forward Looking Statements
This press release may contain statements of a forward-looking nature relating to future events. These forward-looking statements are subject to the inherent uncertainties in predicting future results and conditions. These statements reflect our current beliefs, and a number of important factors could cause actual results to differ materially from those expressed in this press release, including the factors set forth in “Risk Factors” set forth in our Form 10-K and Form 10-Q filed with the Securities and Exchange Commission (“SEC”), and subsequent filings with the SEC. Please refer to our SEC filings for a more detailed discussion of the risks and uncertainties associated with our business, including but not limited to the risks and uncertainties associated with our business prospects and the prospects of our existing and prospective customers; the inherent uncertainty of product development; regulatory, legislative and judicial developments, especially those related to changes in, and the enforcement of, cannabis laws; increasing competitive pressures in our industry; and relationships with our customers and suppliers. Except as required by the federal securities laws, we undertake no obligation to revise or update any forward-looking statements, whether as a result of new information, future events or otherwise. The reference to Surna’s website has been provided as a convenience, and the information contained on such website is not incorporated by reference into this press release.
Non-GAAP Financial Measures
To supplement our financial results on U.S. generally accepted accounting principles (“GAAP”) basis, we use non-GAAP measures including net bookings, backlog, as well as adjusted net income (loss) which reflects adjustments for certain non-cash expenses such as stock-based compensation, certain debt-related items and depreciation expense. We believe these non-GAAP measures are helpful in understanding our past performance and are intended to aid in evaluating our potential future results. The presentation of these non-GAAP measures should be considered in addition to our GAAP results and are not intended to be considered in isolation or as a substitute for financial information prepared or presented in accordance with GAAP. We believe these non-GAAP financial measures reflect an additional way to view aspects of our operations that, when viewed with our GAAP results, provide a more complete understanding of factors and trends affecting our business. For purposes of this press release, (i) “adjusted net income (loss)” and “adjusted operating income (loss)” mean GAAP net income (loss) and operating income (loss), respectively, after adjustment for non-cash equity compensation expense, debt-related items and depreciation expense, and (ii) “net bookings” means new sales contracts executed during the quarter for which we received an initial deposit, net of any adjustments including cancelations and change orders during the quarter.
Our backlog and net bookings may not be indicative of future operating results, and our customers may attempt to renegotiate or terminate their contracts for a number of reasons, including delays in or inability to obtain project financing or licensing or abandonment of the project entirely. Accordingly, there can be no assurance that contracts included in the backlog will actually generate revenues or when the actual revenues will be generated.
Statement about Cannabis Markets
The use, possession, cultivation, and distribution of marijuana is prohibited by U.S. federal law for medical and recreational purposes. Although certain states have legalized medical and recreational cannabis, companies and individuals involved in the sector are still at risk of being prosecuted by federal authorities. Further, the landscape in the cannabis industry changes rapidly. This means that at any time the city, county, or state where cannabis is permitted can change the current laws and/or the federal government can supersede those laws and take prosecutorial action. Given the uncertain legal nature of the cannabis industry, it is imperative that investors understand that investments in the cannabis industry should be considered very high risk. A change in the current laws or enforcement policy can negatively affect the status and operation of our business, require additional fees, stricter operational guidelines and unanticipated shut-downs. Although our customers do, we neither produce nor sell cannabis.
|Director of Marketing|
Condensed Consolidated Balance Sheets (unaudited)
|September 30, 2019||December 31, 2018|
|Cash and cash equivalents||$||2,000,465||$||253,387|
|Accounts receivable (net of allowance for doubtful accounts of $162,152 and $119,022, respectively)||106,621||210,187|
|Total Current Assets||3,739,636||1,527,808|
|Property and equipment, net||289,235||520,321|
|Intangible assets, net||12,075||23,028|
|Operating lease right-of-use asset||580,144||–|
|Total Noncurrent Assets||1,563,518||1,225,413|
|LIABILITIES AND SHAREHOLDERS’ EQUITY|
|Accounts payable and accrued liabilities||$||2,022,173||$||1,917,087|
|Current portion of operating lease liability||213,345||–|
|Total Current Liabilities||4,510,511||2,558,885|
|Operating lease liability||460,901||–|
|Total Noncurrent Liabilities||460,901||–|
|Commitments and Contingencies (Note 6)|
|Preferred stock, $0.00001 par value; 150,000,000 shares authorized; 42,030,331 shares issued and outstanding||420||420|
|Common stock, $0.00001 par value; 350,000,000 shares authorized; 228,216,638 and 224,989,794 shares issued and outstanding, respectively||2,283||2,250|
|Additional paid in capital||25,213,957||24,538,027|
|Total Shareholders’ Equity||331,742||194,336|
|TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY||$||5,303,154||$||2,753,221|
Condensed Consolidated Statements of Operations (unaudited)
|For the Three Months Ended|
|For the Nine Months Ended|
|Cost of revenue||3,943,758||2,228,069||7,987,516||5,385,103|
|Advertising and marketing expenses||123,566||223,474||415,479||658,393|
|Product development costs||98,145||75,448||326,659||207,537|
|Selling, general and administrative expenses||1,081,294||1,460,273||3,284,485||5,121,051|
|Total operating expenses||1,303,005||1,759,195||4,026,623||5,986,981|
|Operating income (loss)||277,342||(662,643||)||(508,411||)||(3,984,990||)|
|Other income (expense):|
|Interest and other income (expense), net||(55,319||)||19,081||(30,146||)||35,571|
|Gain on change in fair value of derivative liabilities||–||–||–||21,403|
|Total other income (expense)||(55,319||)||19,081||(30,146||)||56,939|
|Income (loss) before provision for income taxes||222,023||(643,562||)||(538,557||)||(3,928,051||)|
|Net income (loss)||$||222,023||$||(643,562||)||$||(538,557||)||$||(3,928,051||)|
|Income (loss) per common share – basic and dilutive||$||0.001||$||(0.003||)||$||(0.002||)||$||(0.018||)|
|Weighted average number of common shares outstanding, basic||227,918,377||222,782,404||227,475,335||216,836,968|
|Weighted average number of common shares outstanding, dilutive||237,028,377||222,782,404||227,475,335||216,836,968|
Condensed Consolidated Statements of Cash Flows (unaudited)
|For the Nine Months Ended September 30,|
|Cash Flows From Operating Activities:|
|Adjustments to reconcile net loss to net cash provided by (used in) operating activities:|
|Depreciation and intangible asset amortization expense||129,723||118,999|
|Gain on change in derivative liabilities||–||(21,403||)|
|Compensation paid in equity||675,963||2,067,191|
|Provision for doubtful accounts||43,130||3,682|
|Provision for excess and obsolete inventory||(213,556||)||4,926|
|Loss on disposal of assets||115,359||19,278|
|Changes in operating assets and liabilities:|
|Prepaid expenses and other||(568,031||)||(55,960||)|
|Operating lease right-of-use asset||134,272||–|
|Accounts payable and accrued liabilities||213,044||368,328|
|Net cash provided by (used in) operating activities||1,750,121||(1,716,916||)|
|Cash Flows From Investing Activities|
|Capitalization of intangible assets||–||(2,503||)|
|Purchases of property and equipment||(3,043||)||(232,109||)|
|Proceeds from payment of tenant improvement allowance||–||100,000|
|Cash disbursed for equipment held for lease||–||(16,237||)|
|Net cash used in investing activities||(3,043||)||(150,849||)|
|Cash Flows From Financing Activities|
|Cash proceeds from sale of common stock and warrants||–||1,210,000|
|Proceeds from exercises of stock options||–||3,375|
|Proceeds from exercise of investor warrants||–||15,000|
|Repurchase of common shares from related party||–||(400,000||)|
|Purchase of option to repurchase preferred stock from related party||–||(5,000||)|
|Payments on loans from shareholders||–||(6,927||)|
|Net cash provided by financing activities||–||816,448|
|Net increase (decrease) in cash||1,747,078||(1,051,317||)|
|Cash, beginning of period||253,387||2,468,199|
|Cash, end of period||$||2,000,465||$||1,416,882|
|Supplemental cash flow information:|
|Non-cash investing and financing activities:|
|Equity issued in settlement||$||–||$||226,400|
|Extinguishment of derivative liability on cashless exercise of warrants||$||–||$||389,477|
|Unpaid purchases of equipment and other assets||$||–||$||2,525|
Published at Tue, 12 Nov 2019 22:05:34 +0000